In addition, CCR5 blockage on other cells including cells of the immune system has been proposed to be very effective in reducing CRC burden and its liver metastasis (Halama et al. 2016; Tanabe et al. 2016). This evidence concerns the gene CCR5 and colorectal carcinoma.